Athersys logo
Athersys ATHX
report update icon

Quarterly report 2023-Q3
added 06-27-2026

Athersys ROE Ratio | ATHX

Annual ROE Ratio Athersys

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
304.11 -531.22 -251.15 -191.58 -56.32 -137.92 -137.17 -83.26 -105.68 -155.1 -72.78 -188.35 -126.34 -81.06 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
304.11 -531.22 -129.56

Quarterly ROE Ratio Athersys

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
152.37 532.74 -6738.28 -6763.47 -6896.11 -7200.71 -7749.48 -581.43 -519.6 -425.35 -320.31 -334.18 -306.02 -306.3 -321.4 -274.32 -257.93 -148.92 -68.5 -54.65 -84.43 -92.86 -129.28 -127.18 -134.89 -144.57 -155.67 -93.91 -11.96 -16.39 13.94 -94.18 -143.76 -119.45 -112.42 -85.5 -103.55 -134.79 -187.52 -221.01 -187.58 -315.61 -347.53 -329.39 -371.67 -216.93 -159.56 -159.34 -22.13 -25.1 -53.85

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
532.74 -7749.48 -842.15

ROE Ratio of other stocks in the Biotechnology industry

Issuer ROE Ratio Price % 24h Market Cap Country
scPharmaceuticals scPharmaceuticals
SCPH
-639.25 - - $ 218 M usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
-151.03 - - $ 105 M usaUSA
Global Blood Therapeutics Global Blood Therapeutics
GBT
-154.32 - - $ 4.62 B usaUSA
Inozyme Pharma Inozyme Pharma
INZY
-176.43 - - $ 207 M usaUSA
NanoString Technologies NanoString Technologies
NSTG
-348.24 - -37.43 % $ 5.1 M usaUSA
Humanigen Humanigen
HGEN
151.25 - -81.12 % $ 4.28 M usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
-350.48 $ 3.56 -9.07 % $ 1.58 M usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
3078.97 - -29.58 % $ 126 M usaUSA
Surface Oncology Surface Oncology
SURF
-68.08 - - $ 59.7 M usaUSA
Sierra Oncology Sierra Oncology
SRRA
-98.61 - -0.05 % $ 1.34 B canadaCanada
Vaccinex Vaccinex
VCNX
748.95 - -61.37 % $ 654 K usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
66.3 - -19.68 % $ 18.4 M canadaCanada
Jounce Therapeutics Jounce Therapeutics
JNCE
-27.81 - - $ 98.4 M usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
-139.49 $ 0.93 -4.11 % $ 10.5 M usaUSA
Fortress Biotech Fortress Biotech
FBIO
74.19 $ 1.89 6.78 % $ 52.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
160.08 - -24.86 % $ 820 K usaUSA
Longeveron Longeveron
LGVN
-400.07 $ 1.65 -9.34 % $ 29 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-256.9 - -11.43 % $ 502 K usaUSA
Immunic Immunic
IMUX
1456.2 $ 7.0 -5.28 % $ 1.09 B usaUSA
Immunovant Immunovant
IMVT
-59.3 $ 31.74 -2.4 % $ 5.79 B usaUSA
Mersana Therapeutics Mersana Therapeutics
MRSN
727.65 - - $ 3.56 B usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
-61.07 $ 6.83 1.71 % $ 460 B britainBritain
MediWound Ltd. MediWound Ltd.
MDWD
-126.46 $ 13.59 0.33 % $ 370 M israelIsrael
CymaBay Therapeutics CymaBay Therapeutics
CBAY
-36.05 - - $ 3.45 B usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
-169.75 - - $ 384 M britainBritain
Keros Therapeutics Keros Therapeutics
KROS
28.7 $ 11.04 -3.07 % $ 411 M usaUSA
Kazia Therapeutics Limited Kazia Therapeutics Limited
KZIA
-169.83 $ 4.9 -8.75 % $ 75.9 M australiaAustralia
Allakos Allakos
ALLK
-146.95 - - $ 28.6 M usaUSA
Timber Pharmaceuticals Timber Pharmaceuticals
TMBR
-370.23 - - $ 717 K usaUSA
G1 Therapeutics G1 Therapeutics
GTHX
-135.55 - - $ 370 M usaUSA
Amryt Pharma plc Amryt Pharma plc
AMYT
0.28 - - $ 621 M britainBritain
BioVie BioVie
BIVI
-214.92 $ 0.79 -13.64 % $ 5.72 M usaUSA
Kinnate Biopharma Kinnate Biopharma
KNTE
-70.7 - - $ 123 M usaUSA
Mustang Bio Mustang Bio
MBIO
-20.16 $ 0.35 -4.3 % $ 1.72 M usaUSA
Cerevel Therapeutics Holdings Cerevel Therapeutics Holdings
CERE
-64.24 - - $ 7.29 B usaUSA
NexImmune NexImmune
NEXI
-921.57 - 70.13 % $ 4.12 M usaUSA
Theravance Biopharma Theravance Biopharma
TBPH
35.69 $ 17.03 0.03 % $ 857 M cayman-islandsCayman-islands
Nuvation Bio Nuvation Bio
NUVB
-66.93 $ 3.79 -0.52 % $ 1.29 B usaUSA
IMV IMV
IMV
575.45 - - $ 13.1 M canadaCanada
Chimerix Chimerix
CMRX
-72.64 - - $ 756 M usaUSA
LogicBio Therapeutics LogicBio Therapeutics
LOGC
-130.27 - - $ 229 M usaUSA
AbbVie AbbVie
ABBV
-55.54 $ 286.15 0.94 % $ 506 B usaUSA
89bio 89bio
ETNB
-91.59 - - $ 1.55 B usaUSA
Harpoon Therapeutics Harpoon Therapeutics
HARP
-1254.51 - - $ 763 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
39.76 $ 143.74 -2.76 % $ 18.8 B usaUSA
Amgen Amgen
AMGN
89.06 $ 435.4 -0.21 % $ 234 B usaUSA
RedHill Biopharma Ltd. RedHill Biopharma Ltd.
RDHL
176.55 $ 0.29 -11.35 % $ 3.57 B israelIsrael
Seagen Seagen
SGEN
-21.77 - - $ 42.2 B usaUSA
Baudax Bio Baudax Bio
BXRX
242.53 - 0.59 % $ 63 K usaUSA